Related Experiment Video
Updated: May 19, 2026
10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Managing food allergy in childhood
1Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7280, USA. edwinkim@med.unc.edu
Current Opinion in Pediatrics
|September 1, 2012
Summary
New experimental therapies for food allergy are emerging, including oral immunotherapy and anti-IgE treatments. While promising, further research is essential to confirm long-term safety and effectiveness for patients.
Area of Science:
- Allergy and Immunology
- Experimental Therapeutics
- Diagnostic Technologies
Background:
- Food allergy diagnosis and treatment remain significant clinical challenges.
- Current management often relies on strict avoidance, which can impact quality of life.
Purpose of the Study:
- To review the latest advancements in experimental therapies for food allergy.
- To highlight emerging diagnostic tools and their potential impact.
Main Methods:
- Review of recent scientific literature on food allergy treatments.
- Analysis of data from clinical trials and preclinical studies.
Main Results:
- Epitope mapping and microarray technology show potential for improved diagnostics and prognosis.
- Oral immunotherapy (OIT) increases tolerance but can cause adverse gastrointestinal effects.
- Sublingual immunotherapy appears safer but less effective than OIT.
- Heated food ingestion may accelerate natural allergy resolution.
- Omalizumab (anti-IgE) shows promise as an adjunct or monotherapy.
- Chinese herbal formula FAHF-2 demonstrates safety and potential efficacy in early studies.
Conclusions:
- Advanced diagnostic methods are expected to improve food allergy diagnosis accuracy.
- Novel therapeutic strategies are nearing clinical application.
- Long-term safety and efficacy data are required for emerging food allergy treatments.
Related Concept Videos
02:06Allergic Reactions
Overview
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...